Viewing Study NCT02293967


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-03-09 @ 12:19 AM
Study NCT ID: NCT02293967
Status: COMPLETED
Last Update Posted: 2015-03-17
First Post: 2014-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mass Balance Study of MT-1303
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing-remitting Multiple Sclerosis View
Keywords: